ELISA Kit for Bone Morphogenetic Protein 9 (BMP9)

GDF2; Growth Differentiation Factor 2

  • ELISA Kit for Bone Morphogenetic Protein 9 (BMP9) Packages (Simulation)
  • ELISA Kit for Bone Morphogenetic Protein 9 (BMP9) Packages (Simulation)
  • ELISA Kit for Bone Morphogenetic Protein 9 (BMP9) Results demonstration
  • SEB728Ra.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the ELISA Kit for Bone Morphogenetic Protein 9 (BMP9)

This assay has high sensitivity and excellent specificity for detection of Bone Morphogenetic Protein 9 (BMP9).
No significant cross-reactivity or interference between Bone Morphogenetic Protein 9 (BMP9) and analogues was observed.

Recovery of the ELISA Kit for Bone Morphogenetic Protein 9 (BMP9)

Matrices listed below were spiked with certain level of recombinant Bone Morphogenetic Protein 9 (BMP9) and the recovery rates were calculated by comparing the measured value to the expected amount of Bone Morphogenetic Protein 9 (BMP9) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 90-99 96
EDTA plasma(n=5) 80-95 90
heparin plasma(n=5) 81-101 90

Precision of the ELISA Kit for Bone Morphogenetic Protein 9 (BMP9)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Bone Morphogenetic Protein 9 (BMP9) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Bone Morphogenetic Protein 9 (BMP9) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the ELISA Kit for Bone Morphogenetic Protein 9 (BMP9)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Bone Morphogenetic Protein 9 (BMP9) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 98-105% 78-103% 95-104% 91-98%
EDTA plasma(n=5) 88-103% 83-90% 88-104% 80-103%
heparin plasma(n=5) 83-104% 91-98% 86-93% 79-88%

Stability of the ELISA Kit for Bone Morphogenetic Protein 9 (BMP9)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the ELISA Kit for Bone Morphogenetic Protein 9 (BMP9)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

Test principle of the ELISA Kit for Bone Morphogenetic Protein 9 (BMP9)

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Bone Morphogenetic Protein 9 (BMP9). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Bone Morphogenetic Protein 9 (BMP9). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Bone Morphogenetic Protein 9 (BMP9), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Bone Morphogenetic Protein 9 (BMP9) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Related products

Catalog No. Organism species: Rattus norvegicus (Rat) Applications (RESEARCH USE ONLY!)
RPB728Ra01 Recombinant Bone Morphogenetic Protein 9 (BMP9) Positive Control; Immunogen; SDS-PAGE; WB.
PAB728Ra01 Polyclonal Antibody to Bone Morphogenetic Protein 9 (BMP9) WB; IHC; ICC; IP.
MAB728Ra21 Monoclonal Antibody to Bone Morphogenetic Protein 9 (BMP9) WB; IHC; ICC; IP.
SEB728Ra ELISA Kit for Bone Morphogenetic Protein 9 (BMP9) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB728Ra CLIA Kit for Bone Morphogenetic Protein 9 (BMP9) Chemiluminescent immunoassay for Antigen Detection.
LMB728Ra Multiplex Assay Kit for Bone Morphogenetic Protein 9 (BMP9) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK